Karyotypic evolution pathways in medulloblastoma/primitive neuroectodermal tumor determined with a combination of spectral karyotyping, G-banding, and fluorescence in situ hybridization

Cancer Genetics and Cytogenetics

Volumn 149, Issue 1, 2004, Pages 44-52

  Cohen, Ninette ^a   Betts, David R ^b   Tavori, Uri ^a   Toren, Amos ^a   Ram, Tzvi ^a   Constantini, Shlomi ^c   Grotzer, Michael A ^b   Amariglio, Ninette ^a   Rechavi, Gideon ^a   Trakhtenbrot, Luba ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; CHROMOSOME 1; CHROMOSOME 13; CHROMOSOME 14; CHROMOSOME 19; CHROMOSOME 21; CHROMOSOME 22; CHROMOSOME 7; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME STRUCTURE; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MEDULLOBLASTOMA; MOLECULAR CLONING; MOLECULAR EVOLUTION; NEUROECTODERM TUMOR; POLYPLOIDY; PRIORITY JOURNAL; SPECTRAL KARYOTYPING; STRUCTURE ANALYSIS; TUMOR CELL LINE; X CHROMOSOME ABERRATION;

EID: 10744232880     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00285-1     Document Type: Article

References (38)

1. Zulch K.J. Medulloblastomas. Zulch K.J. Brain tumors. 3rd edition :1986;324-325 Springer-Verlag, Berlin.
2. Louis D.N., Pomeroy S.L., Cairncross J.G. Focus on central nervous system neoplasia. Cancer Cell. 1:2002;125-128.
3. Kadin M.E., Rubinstein L.J., Nelson J.S. Neonatal cerebellar medulloblastoma originating from the fetal external granular layer. J Neuropathol Exp Neurol. 29:1970;583-600.
4. Rorke L.B. The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol. 42:1983;1-15.
5. Pomeroy S.L., Tamayo P., Gaasenbeek M., Sturla L.M., Angelo M., McLaughlin M.E., Kim J.Y., Goumnerova L.C., Black P.M., Lau C., Allen J.C., Zagzag D., Olson J.M., Curran T., Wetmore C., Biegel J.A., Poggio T., Mukherjee S., Rifkin R., Califano A., Stolovitzky G., Louis D.N., Mesirov J.P., Lander E.S., Golub T.R. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 415:2002;436-442.
6. Segal R.A., Goumnerova L.C., Kwon Y.K., Stiles C.D., Pomeroy S.L. Expression of the neurotrophin receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci U S A. 91:1994;12867-12871.
7. Gilbertson R.J., Perry R.H., Kelly P.J., Pearson A.D., Lunec J. Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. Cancer Res. 57:1997;3272-3280.
8. Kim J.Y., Sutton M.E., Lu D.J., Cho T.A., Goumnerova L.C., Goritchenko L., Kaufman J.R., Lam K.K., Billet A.L., Tarbell N.J., Wu J., Allen J.C., Stiles C.D., Segal R.A., Pomeroy S.L. Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. Cancer Res. 59:1999;711-719.
9. Herms J., Neidt I., Luscher B., Sommer A., Schurmann P., Schroder T., Bergmann M., Wilken B., Probst-Cousin S., Hernaiz-Driever P., Behnke J., Hanefeld F., Pietsch T., Kretzschmar H.A. C-MYC expression in medulloblastoma and its prognostic value. Int J Cancer. 89:2000;395-402.
10. Grotzer M.A., Hogarty M.D., Janss A.J., Liu X., Zhao H., Eggert A., Sutton L.N., Rorke L.B., Brodeur G.M., Phillips P.C. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clin Cancer Res. 7:2001;2425-2433.
11. Griffin C.A., Hawkins A.L., Packer R.J., Rorke L.B., Emanuel B.S. Chromosome abnormalities in pediatric brain tumors. Cancer Res. 48:1988;175-180.
12. Bigner S.H., Mark J., Friedman H.S., Biegel J.A., Bigner D.D. Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet Cytogenet. 30:1988;91-101.
13. Biegel J.A., Rorke L.B., Packer R.J., Sutton L.N., Schut L., Bonner K., Emanuel B.S. Isochromosome 17q in primitive neuroectodermal tumors of the central nervous system. Genes Chromosomes Cancer. 1:1989;139-147.
14. Giordana M.T., Migheli A., Pavanelli E. Isochromosome 17q is a constant finding in medulloblastoma: an interphase cytogenetic study on tissue sections. Neuropathol Appl Neurobiol. 24:1998;233-238.
15. Biegel J.A. Cytogenetics and molecular genetics of childhood brain tumors. Neuro-oncol. 1:1999;139-151.
16. Nam D.H., Wang K.C., Kim Y.M., Chi J.G., Kim S.K., Cho B.K. The effect of isochromosome 17q presence, proliferative and apoptotic indices, expression of c-erbB-2, bcl-2 and p53 proteins on the prognosis of medulloblastoma. J Korean Med Sci. 15:2000;452-456.
17. Bigner S.H., Friedman H.S., Vogelstein B., Oakes W.J., Bigner D.D. Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res. 50:1990;2347-2350.
18. Aldosari N., Bigner S.H., Burger P.C., Becker L., Kepner J.L., Friedman H.S., McLendon R.E. MYCC and MYCN oncogene amplification in medulloblastoma: a fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group. Arch Pathol Lab Med. 126:2002;540-544.
19. Michiels E.M., Weiss M.M., Hoovers J.M., Baak J.P., Voute P.A., Baas F., Hermsen M.A. Genetic alterations in childhood medulloblastoma analyzed by comparative genomic hybridization. J Pediatr Hematol Oncol. 24:2002;205-210.
20. Schrock E., du Manoir S., Veldman T., Schoell B., Wienberg J., Ferguson-Smith M.A., Ning Y., Ledbetter D.H., Bar-Am I., Soenksen D., Garini Y., Ried T. Multicolor spectral karyotyping of human chromosomes. Science. 273:1996;494-497.
21. Veldman T., Vignon C., Schrock E., Rowley J.D., Ried T. Hidden chromosome abnormalities in hematological malignancies detected by multicolor spectral karyotyping. Nat Genet. 15:1997;406-410.
22. Rao P.H., Cigudosa J.C., Ning Y., Calasanz M.J., Iida S., Tagawa S., Michaeli J., Klein B., Dalla-Favera R., Jhanwar S.C., Ried T., Chaganti R.S.K. Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma. Blood. 92:1998;1743-1748.
23. Zattara-Cannoni H., Dufour H., Lepidi H., Chatel C., Grisoli F., Vagner-Capodano A.M. Hidden chromosome abnormalities in a primary central nervous system lymphoma detected by multicolor spectral karyotyping. Cancer Genet Cytogenet. 107:1998;98-101.
24. Fleischman E., Reshmi S., Sokova O.I., Kirichenko O.P., Konstantinova L.N., Kulagina O.E., Frenkel M.A., Rowley J.D. Increased karyotype precision using fluorescence in situ hybridization and spectral karyotyping in patients with myeloid malignancies. Cancer Genet Cytogenet. 108:1999;166-170.
25. Bayani J., Squire J.A. Advances in the detection of chromosomal aberrations using spectral karyotyping. Clin Genet. 9:2001;65-73.
26. Cohen N., Betts D.R., Trakhtenbrot L., Niggli F.K., Amariglio N., Brok-Simoni F., Rechavi G., Meitar D. Detection of unidentified chromosome abnormalities in human neuroblastoma by spectral karyotyping (SKY). Genes Chromosomes Cancer. 31:2001;201-208.
27. Aldosari N., Wiltshire R.N., Dutra A., Schrock E., McLendon R.E., Friedman H.S., Bigner D.D., Bigner S.H. Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft. Neuro-oncol. 4:2002;75-85.
28. Bayani J., Zielenska M., Marrano P., Kwan Y., Taylor M.D., Jay V., Rutka J.T., Squire J.A. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping. J Neurosurg. 93:2000;437-448.
29. Betts D.R., Koesters R., Pluss H.J., Niggli F.K. Routine karyotyping in Wilms tumor. Cancer Genet Cytogenet. 96:1997;151-156.
30. Cohen N., Novikov I., Hardan I., Esa A., Brok-Simoni F., Amariglio N., Rechavi G., Ben-Bassat I., Trakhtenbrot L. Standardization criteria for the detection of BCR/ABL fusion in interphase nuclei of chronic myelogenous leukemia patients by fluorescence in situ hybridization. Cancer Genet Cytogenet. 123:2000;102-108.
31. Fults D., Pedone C.A., Morse H.G., Rose J.W., McKay R.D. Establishment and characterization of a human primitive neuroectodermal tumor cell line from the cerebral hemisphere. J Neuropathol Exp Neurol. 51:1992;272-280.
32. Gilhuis H.J., Anderl K.L., Boerman R.H., Jeuken J.M., James C.D., Raffel C., Scheithauer B.W., Jenkins R.B. Comparative genomic hybridization of medulloblastomas and clinical relevance: eleven new cases and a review of the literature. Clin Neurol Neurosurg. 102:2000;203-209.
33. Avet-Loiseau H., Venuat A.M., Terrier-Lacombe M.J., Lellouch-Tubiana A., Zerah M., Vassal G. Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children. Br J Cancer. 79:1999;1843-1847.
34. Nicholson J., Wickramasinghe C., Ross F., Crolla J., Ellison D. Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation. Mol Pathol. 53:2000;313-319.
35. Bigner S.H., McLendon R.E., Fuchs H., McKeever P.E., Friedman H.S. Chromosomal characteristics of childhood brain tumors. Cancer Genet Cytogenet. 97:1997;125-134.
36. Neumann E., Kalousek D.K., Norman M.G., Steinbok P., Cochrane D.D., Goddard K. Cytogenetic analysis of 109 pediatric central nervous system tumors. Cancer Genet Cytogenet. 71:1993;40-49.
37. Reardon D.A., Michalkiewicz E., Boyett J.M., Sublett J.E., Entrekin R.E., Ragsdale S.T., Valentine M.B., Behm F.G., Li H., Heideman R.L., Kun L.E., Shapiro D.N., Look A.T. Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization. Cancer Res. 57:1997;4042-4047.
38. Fults D., Petronio J., Noblett B.D., Pedone C.A. Chromosome 11p15 deletions in human malignant astrocytomas and primitive neuroectodermal tumors. Genomics. 14:1992;799-801.